ANDREAS REIMOLD, MD
Osteopathic Medicine at Harry Hines Blvd, Dallas, TX
License number
Texas L0536
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
5323 Harry Hines Blvd, Dallas, TX 75390
Phone
(214) 645-0624
(214) 645-0078 (Fax)
(214) 645-0078 (Fax)
Personal information
See more information about ANDREAS REIMOLD at radaris.comName
Address
Phone
6106 Boca Raton Dr, Dallas, TX 75230
Dallas, TX
6106 Boca Raton Dr, Dallas, TX 75230
Organization information
See more information about ANDREAS REIMOLD at bizstanding.comAndreas Reimold MD
5323 Harry Hines Blvd, Dallas, TX 75390
Industry:
Internist
Phone:
(214) 648-8706 (Phone)
Andreas Michael Reimold
Professional information
Dr. Andreas Reimold, Dallas TX - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
UT Southwestern Rheumatology
5303 Harry Hines Blvd SUITE 400, Dallas 75390
(214) 645-2800 (Phone)
5303 Harry Hines Blvd SUITE 400, Dallas 75390
(214) 645-2800 (Phone)
Procedures:
Joint Drainage, Steroid Injections
Conditions:
Arthritis, Carpal Tunnel Syndrome, Chronic Neck Pain, Degenerative Disc Disease, Dermatomyositis, Dupuytren's Contracture, Fibromyalgia, Giant Cell Arteritis, Gout, Hammer Toe, Low Back Pain, Lupus Erythematosus, Osteoarthritis, Osteoarthritis of Hand or Wrist, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Polymyalgia Rheumatica (PMR), Polymyositis, Raynaud's Disease, Reiter's Syndrome (Reactive Arthritis), Rheumatoid Arthritis, Sarcoidosis, Scleroderma, Sjögren's Syndrome, Spondylitis, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Wegener's Granulomatosis
Certifications:
Internal Medicine, 1987, Rheumatology, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UT Southwestern Rheumatology
5303 Harry Hines Blvd SUITE 400, Dallas 75390
Ut Southwestern University Hospital - Zale Lipshy
5151 Harry Hines Blvd, Dallas 75235
5303 Harry Hines Blvd SUITE 400, Dallas 75390
Ut Southwestern University Hospital - Zale Lipshy
5151 Harry Hines Blvd, Dallas 75235
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1984
Barnes Hosp/Wash U
Brigham and Womens Hospital
Columbia University / College of Physicians And Surgeons
Graduated: 1984
Barnes Hosp/Wash U
Brigham and Womens Hospital
Andreas M Reimold, Dallas TX
Specialties:
Rheumatologist
Address:
5323 Harry Hines Blvd, Dallas, TX 75390
Ut Southwestern Medical Ctr, Dallas, TX 75390
Limited For University Duties Only, Dallas, TX 75390
Ut Southwestern Medical Ctr, Dallas, TX 75390
Limited For University Duties Only, Dallas, TX 75390
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine
Brigham & Women's Hospital - Fellowship - Rheumatology (Internal Medicine)
Barnes-Jewish Hospital - Residency - Internal Medicine
Brigham & Women's Hospital - Fellowship - Rheumatology (Internal Medicine)
Barnes-Jewish Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Rheumatology (Internal Medicine)
Andreas Reimold, Dallas TX
Specialties:
Internal Medicine, Rheumatology
Work:
Va North Texas Health Care System: Dallas Va Medical Center
4500 S Lancaster Rd, Dallas, TX 75216 Univ TX Southwestern Med Ctr
5323 Harry Hines Blvd, Dallas, TX 75390
4500 S Lancaster Rd, Dallas, TX 75216 Univ TX Southwestern Med Ctr
5323 Harry Hines Blvd, Dallas, TX 75390
Education:
Columbia University (1984)
Methods And Compositions Relating To Modulation Of Hepatocyte Growth, Plasma Cell Differentiation Or T Cell Subset Activity By Modulation Of Xbp-1 Activity
US Patent:
7358415, Apr 15, 2008
Filed:
Aug 19, 2003
Appl. No.:
10/643581
Inventors:
Laurie H. Glimcher - West Newton MA, US
Andreas M. Reimold - Dallas TX, US
Andreas M. Reimold - Dallas TX, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
G01N 33/00, C12Q 1/86
US Classification:
800 3, 435 6, 435 71, 435973
Abstract:
The invention demonstrates that the transcription factor XBP-1 is a regulator of hepatocyte growth, plasma cell differentiation and T cell subset activity. Methods for identifying modulators of hepatocyte growth, plasma cell differentiation and/or T cell subset activity, using XBP-1-containing indicator compositions or XBP-1-deficient cells, are provided. Methods of modulating hepatocyte growth, plasma cell differentiation and/or T cell subset activity (e. g. , Th2 cytokine production) using agents that modulate the activity of XBP-1 are also provided. Methods for diagnosing disorders associated with aberrant hepatocyte growth, plasma cell differentiation and/or T cell subset activity, by assessing a change in XBP-1 expression, are also provided. XBP-1 deficient cells, animals and embryos, as well as kits for the methods of the invention, are also provided by the invention.
Methods And Compositions Relating To Modulation Of Hepatocyte Growth, Plasma Cell Differentiation Or T Cell Subset Activity By Modulation Of Xbp-1 Activity
US Patent:
2002005, May 16, 2002
Filed:
Dec 29, 2000
Appl. No.:
09/753346
Inventors:
Laurie Glimcher - West Newton MA, US
Andreas Reimold - Dallas TX, US
Andreas Reimold - Dallas TX, US
International Classification:
G01N033/53, G01N033/00, A61K048/00
US Classification:
800/003000, 514/044000, 435/007100
Abstract:
The invention demonstrates that the transcription factor XBP-1 is a regulator of hepatocyte growth, plasma cell differentiation and T cell subset activity. Methods for identifying modulators of hepatocyte growth, plasma cell differentiation and/or T cell subset activity, using XBP-1-containing indicator compositions or XBP-1-deficient cells, are provided. Methods of modulating hepatocyte growth, plasma cell differentiation and/or T cell subset activity (e.g., Th2 cytokine production) using agents that modulate the activity of XBP-1 are also provided. Methods for diagnosing disorders associated with aberrant hepatocyte growth, plasma cell differentiation and/or T cell subset activity, by assessing a change in XBP-1 expression, are also provided. XBP-1 deficient cells, animals and embryos, as well as kits for the methods of the invention, are also provided by the invention.
Methods And Compositions Relating To Modulation Of Hepatocyte Growth, Plasma Cell Differentiation Or T Cell Subset Activity By Modulation Of Xbp-1 Activity
US Patent:
2008024, Oct 2, 2008
Filed:
Feb 7, 2008
Appl. No.:
12/069073
Inventors:
Laurie H. Glimcher - West Newton MA, US
Andreas M. Reimold - Dallas TX, US
Andreas M. Reimold - Dallas TX, US
International Classification:
A61K 35/12, C12Q 1/04, G01N 33/50, A61P 43/00, C12N 5/02
US Classification:
424 9321, 435 34, 800 3, 435375, 435377
Abstract:
The invention demonstrates that the transcription factor XBP-1 is a regulator of hepatocyte growth, plasma cell differentiation and T cell subset activity. Methods for identifying modulators of hepatocyte growth, plasma cell differentiation and/or T cell subset activity, using XBP-1-containing indicator compositions or XBP-1-deficient cells, are provided. Methods of modulating hepatocyte growth, plasma cell differentiation and/or T cell subset activity (e.g., Th2 cytokine production) using agents that modulate the activity of XBP-1 are also provided. Methods for diagnosing disorders associated with aberrant hepatocyte growth, plasma cell differentiation and/or T cell subset activity, by assessing a change in XBP-1 expression, are also provided. XBP-1 deficient cells, animals and embryos, as well as kits for the methods of the invention, are also provided by the invention.